Addex Therapeutics Ltd Revenue And Operating Income
Addex Therapeutics Ltd (ADXN) reported Revenue And Operating Income of CHF 36.38 thousand for the 3-month period ending 2025-06-30, per its 6-K filed 2025-09-30.
Financial Statements › Income Statement › Other Income
ifrs-full:RevenueAndOperatingIncome · last filed 2025-09-30
- Addex Therapeutics Ltd revenue and operating income for the quarter ending 2025-06-30 was 36.38K CHF, a 68.45% decline year-over-year.
- Addex Therapeutics Ltd revenue and operating income for the quarter ending 2024-06-30 was 115.28K CHF, a 81.76% decline year-over-year.
- Addex Therapeutics Ltd revenue and operating income for the quarter ending 2023-06-30 was 631.98K CHF, a 238.97% increase year-over-year.
- Addex Therapeutics Ltd revenue and operating income for the quarter ending 2022-06-30 was 186.44K CHF, a 82.61% decline year-over-year.
| Period end | Revenue And Operating Income 3 month | Revenue And Operating Income 6 month | Revenue And Operating Income 12 month | Revenue And Operating Income 12 month as first filed |
|---|---|---|---|---|
| 2025-06-30 | 36.38K CHF 6-K · filed 2025-09-30 | 107.43K CHF 6-K · filed 2025-09-30 | ||
| 2024-12-31 | 410.04K CHF 20-F · filed 2025-05-15 | |||
| 2024-06-30 | 115.28K CHF 6-K · filed 2025-09-30 | 350.19K CHF 6-K · filed 2025-09-30 | ||
| 2023-12-31 | 1.62M CHF 20-F · filed 2025-05-15 | 1.65M CHF 20-F · filed 2024-04-18 | ||
| 2023-06-30 | 631.98K CHF 6-K/A · filed 2023-12-21 | 1.13M CHF 6-K/A · filed 2023-12-21 | ||
| 2022-12-31 | 1.44M CHF 20-F · filed 2025-05-15 | |||
| 2022-06-30 | 186.44K CHF 6-K/A · filed 2023-12-21 | 430.39K CHF 6-K/A · filed 2023-12-21 | ||
| 2021-12-31 | 3.15M CHF 20-F · filed 2024-04-18 | |||
| 2021-06-30 | 1.07M CHF 6-K/A · filed 2022-09-14 | 1.99M CHF 6-K/A · filed 2022-09-14 | ||
| 2020-12-31 | 3.88M CHF 20-F · filed 2023-03-30 | |||
| 2019-12-31 | 2.83M CHF 20-F · filed 2022-03-10 | |||
| 2018-12-31 | 6.70M CHF 20-F · filed 2021-03-11 | |||
| 2017-12-31 | 499.89K CHF 20-F · filed 2020-04-27 |